Novaliq is a biopharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first and only water-free technology worldwide for ophthalmology products.
EyeSol® – our unique and versatile water-free technology
Our late-stage clinical stage drug developments provide unique therapeutic options for millions of diagnosed but untreated or undertreated dry eye patients are in development:
CyclASol® has the potential to change the way eye care practitioners treat patients with dry eye disease
NovaTears® is the first water-free eye drop based on EyeSol® developed for the treatment of dry eye. Novatears® is CE certified since 2014 and successfully commercialized in Australia/New Zealand and in Europe by our partners.
Reach more about our latest press releases, key scientificpublications and other company resources
© Realization: formativ.net oHG